Skip to main content

Table 2 Laboratory findings of the patients before matching

From: Relationship between systemic immune inflammation index and development of complete atrioventricular block in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Variables

CAVB (-)

(n = 835)

CAVB (+)

(n = 48)

p-value

WBC count (×103/µL)

11.8 ± 3.8

13.1 ± 4.2

0.019

Hemoglobin (g/dl)

14.1 ± 1.9

12.4 ± 1.9

< 0.001

eGFR* (mL/min/1.73m2)

90 (73–108)

67 (37–82)

< 0.001

Platelet count (×103/µL)

267 ± 77

313 ± 110

< 0.001

Neutrophil (×103/µL)

8.1 ± 3.6

10.1 ± 3.7

< 0.001

Lymphocyte (×103/µL)

2.7 ± 1.6

2.1 ± 0.8

< 0.001

Total cholesterol (mg/dL)

184 ± 48

166 ± 46

0.050

LDL-C (mg/dL)

114.5 ± 37.9

102.8 ± 36.3

0.110

HDL-C (mg/dL)

37.1 ± 11.7

37.5 ± 15.9

0.852

Trigliseride * (mg/dL)

141 (102–195)

115 (92–182)

0.168

LVEF *

46.3 ± 10.0

42.8 ± 9.2

0.021

SII* (x109/L)

771 (427–1462)

1370 (1050–1779)

< 0.001

  1. Abbreviations: WBC; white blood cell, eGFR: estimated glomerular filtration rate, LVEF: left ventricular ejection fraction, SII; systemic immune-inflammatory index, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol
  2. * Comparison was made using the Mann-Whitney U test at p < 0.05, and these values were described by a median with an interquartile range (25th and 75th percentile)